FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971877017> ?p ?o ?g. }

• W1971877017 endingPage "1024" @default.
• W1971877017 startingPage "1017" @default.
• W1971877017 abstract "This study was designed to evaluate the benefits of neoadjuvant chemotherapy prior to chemoradiation and surgery in patients with locally advanced rectal cancer. Patients with previously untreated primary rectal cancer, reviewed in a multidisciplinary meeting and considered to have locally advanced disease on the basis of physical examination and imaging (MRI+CT n=30, CT alone n=6), were recruited. Patients received protracted venous infusion 5-FU (300 mg m−2 day−1 for 12 weeks) with mitomycin C (MMC) (7 mg m−2 i.v. bolus every 6 weeks). Starting on week 13, 5-FU was reduced to 200 mg m−2 day−1 and concomitant pelvic radiotherapy 45 Gy in 25 fractions was commenced followed by 5.4–9 Gy boost to tumour bed. Surgery was planned 6 weeks after chemoradiation. Postoperatively, patients received 12 weeks of MMC and 5-FU at the same preoperative doses. Between January 99 and August 01, 36 eligible patients were recruited. Median age was 63 years (range=40–85). Following neoadjuvant chemotherapy, radiological tumour response was 27.8% (one CR and nine PRs) and no patient had progressive disease. In addition, 65% of patients had a symptomatic response including improvement in diarrhoea/constipation (59%), reduced rectal bleeding (60%) and diminished pelvic pain/tenesmus (78%). Following chemoradiation, tumour regression occurred in 80.6% (six CRs and 23 PRs; 95% CI=64–91.8%) and only one patient still had an inoperable tumour. R0 resection was achieved in 28 patients (82%). When compared with initial clinical staging, the pathological downstaging rate in T and/or N stage was 73.5% and pathological CR was found in one patient. Neoadjuvant systemic chemotherapy as a prelude to synchronous chemoradiation can be administered with negligible risk of disease progression and produces considerable symptomatic response with associated tumour regression." @default.
• W1971877017 created "2016-06-24" @default.
• W1971877017 creator A5015019664 @default.
• W1971877017 creator A5021613383 @default.
• W1971877017 creator A5023423900 @default.
• W1971877017 creator A5023777741 @default.
• W1971877017 creator A5025120810 @default.
• W1971877017 creator A5028909668 @default.
• W1971877017 creator A5033436753 @default.
• W1971877017 creator A5037338885 @default.
• W1971877017 creator A5051974926 @default.
• W1971877017 creator A5052891683 @default.
• W1971877017 creator A5056345420 @default.
• W1971877017 creator A5079536033 @default.
• W1971877017 creator A5084395158 @default.
• W1971877017 date "2003-04-01" @default.
• W1971877017 modified "2023-10-16" @default.
• W1971877017 title "Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer" @default.
• W1971877017 cites W1492190372 @default.
• W1971877017 cites W1585172067 @default.
• W1971877017 cites W17865611 @default.
• W1971877017 cites W1884971637 @default.
• W1971877017 cites W1899767765 @default.
• W1971877017 cites W1919629952 @default.
• W1971877017 cites W1939228419 @default.
• W1971877017 cites W1968588574 @default.
• W1971877017 cites W1974902120 @default.
• W1971877017 cites W1975061972 @default.
• W1971877017 cites W1981378981 @default.
• W1971877017 cites W2000798662 @default.
• W1971877017 cites W2003706429 @default.
• W1971877017 cites W2012613876 @default.
• W1971877017 cites W2016110260 @default.
• W1971877017 cites W2021416608 @default.
• W1971877017 cites W2022848495 @default.
• W1971877017 cites W2034960787 @default.
• W1971877017 cites W2043126937 @default.
• W1971877017 cites W2046311020 @default.
• W1971877017 cites W2049101443 @default.
• W1971877017 cites W2075925486 @default.
• W1971877017 cites W2078103786 @default.
• W1971877017 cites W2082048528 @default.
• W1971877017 cites W2083716454 @default.
• W1971877017 cites W2088532421 @default.
• W1971877017 cites W2096122707 @default.
• W1971877017 cites W2098817044 @default.
• W1971877017 cites W2099015389 @default.
• W1971877017 cites W2102583333 @default.
• W1971877017 cites W2109558652 @default.
• W1971877017 cites W2115322358 @default.
• W1971877017 cites W2121368761 @default.
• W1971877017 cites W2121761389 @default.
• W1971877017 cites W2127699440 @default.
• W1971877017 cites W2128069972 @default.
• W1971877017 cites W2132565869 @default.
• W1971877017 cites W2143863553 @default.
• W1971877017 cites W2145615263 @default.
• W1971877017 cites W2148566563 @default.
• W1971877017 cites W2162313061 @default.
• W1971877017 cites W2167805334 @default.
• W1971877017 cites W2319588241 @default.
• W1971877017 cites W4293241248 @default.
• W1971877017 doi "https://doi.org/10.1038/sj.bjc.6600822" @default.
• W1971877017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2376366" @default.
• W1971877017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12671697" @default.
• W1971877017 hasPublicationYear "2003" @default.
• W1971877017 type Work @default.
• W1971877017 sameAs 1971877017 @default.
• W1971877017 citedByCount "71" @default.
• W1971877017 countsByYear W19718770172012 @default.
• W1971877017 countsByYear W19718770172013 @default.
• W1971877017 countsByYear W19718770172014 @default.
• W1971877017 countsByYear W19718770172015 @default.
• W1971877017 countsByYear W19718770172016 @default.
• W1971877017 countsByYear W19718770172018 @default.
• W1971877017 countsByYear W19718770172020 @default.
• W1971877017 countsByYear W19718770172021 @default.
• W1971877017 countsByYear W19718770172022 @default.
• W1971877017 countsByYear W19718770172023 @default.
• W1971877017 crossrefType "journal-article" @default.
• W1971877017 hasAuthorship W1971877017A5015019664 @default.
• W1971877017 hasAuthorship W1971877017A5021613383 @default.
• W1971877017 hasAuthorship W1971877017A5023423900 @default.
• W1971877017 hasAuthorship W1971877017A5023777741 @default.
• W1971877017 hasAuthorship W1971877017A5025120810 @default.
• W1971877017 hasAuthorship W1971877017A5028909668 @default.
• W1971877017 hasAuthorship W1971877017A5033436753 @default.
• W1971877017 hasAuthorship W1971877017A5037338885 @default.
• W1971877017 hasAuthorship W1971877017A5051974926 @default.
• W1971877017 hasAuthorship W1971877017A5052891683 @default.
• W1971877017 hasAuthorship W1971877017A5056345420 @default.
• W1971877017 hasAuthorship W1971877017A5079536033 @default.
• W1971877017 hasAuthorship W1971877017A5084395158 @default.
• W1971877017 hasBestOaLocation W19718770171 @default.
• W1971877017 hasConcept C121608353 @default.
• W1971877017 hasConcept C126322002 @default.
• W1971877017 hasConcept C141071460 @default.
• W1971877017 hasConcept C2776694085 @default.

• next